FDA and the National Center for Advancing Translational Sciences update the CURE ID crowd-sourcing drug repurposing app.
The LUNGevity Foundation says many lung cancer therapies are in development, including some relying on biomarkers.
FDA grants Mustang Bio an orphan drug designation for MB-106, a CD20-targeted, autologous CAR T cell therapy for treating Waldenstrom macroglobulinemi...
U.S. Senators Jeanne Shaheen (D-NH) and Susan Collins (R-ME) reveal bipartisan legislation entitled Improving Needed Safeguards for Users of Lifesavin...
Two drug stakeholder associations ask FDA to reconsider its proposal that opioid manufacturers provide mail-back envelopes to use in disposing of opio...
BD says it is recalling intraosseous products that have several issues.
The Menarini Group submits an NDA for elacestrant and its use in patients with ER+/HER2 advanced or metastatic breast cancer.
CBER updates its guidance agenda for 2022 containing 18 guidances it plans to develop.